IQVIA Laboratories at SfN 2026
Nov 14–18, 2026 Washington, DC ~21k attendees Website
IQVIA Laboratories brings 5 presentations to SfN 2026 in Washington, and exhibits at Booth 1407. Its program at this meeting centres on brain-disease models and imaging, including migraine, epilepsy and changes in blood flow or blood-brain barrier function. One study uses fractionated kainic acid dosing and seizure imaging in a chronic epilepsy model.
| Organization | SfN 2026 Attendance |
|---|---|
IQVIA Laboratories Kuopio, Finland | |
Central laboratory and bioanalytical services provider for clinical trials, part of IQVIA. | Booth Exhibiting at Booth 1407 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sat Nov 14 1–5pm Poster Sun Nov 15 8am–noon Talk Mon Nov 16 11:30am–noon Poster Wed Nov 18 1–5pm |
Instantly find 20 buyers from IQVIA Laboratories
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction